KURA FY 2010 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$792M

FY 2010 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$20,509

Operating Income

-$41,018

Net Income

-$22,395

EPS (Diluted)

$-0.00

Cash Flow

Operating Cash Flow

-$19,244

Free Cash Flow

-$19,244

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$29,398

Total Liabilities

$70,389

Stockholders' Equity

-$40,991

Cash & Equivalents

$26,898

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$20,509	-$19,158	-7.1%
Operating Income	-$41,018	-$38,316	-7.1%
Net Income	-$22,395	-$19,996	-12.0%